TAT and cancer: In vitro flow cytometry demonstrated Tat-A1E28 and Tat-A4V48 bound to MDA MB231 human breast and 4T1 murine cancer cells markedly more than E28 and Tat-E28, which exhibited minimal binding (Fig. 1c and d).